Param Dedhia
Internal Medicine · Baltimore, MDNPI 1396780136
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $592,200 of the $636,143 with a category attached, or 93.1%. Siemens Medical Solutions USA, Inc. accounts for 99.9% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $472,738, more than ten times the $115 reported in 2021. Among internal medicine clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $10,260 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$636K
- AbbVie$94
- Amgen$87
- Kowa Pharmaceuticals America, Inc.$45
- CSL Behring$43
- Lilly USA, LLC$32
- plus $222 from 11 others
What the payments were for
- Speaking & faculty fees$592,20093%
- Travel & lodging$41,8917%
- Food & beverage$2,0520%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 31 | $635,619 |
| AbbVie | 6 | $94 |
| Amgen | 4 | $87 |
| Kowa Pharmaceuticals America, Inc. | 3 | $45 |
| CSL Behring | 2 | $43 |
| Lilly USA, LLC | 2 | $32 |
| Bayer | 2 | $32 |
| Nestle Healthcare Nutrition Inc. | 2 | $31 |
| Boehringer Ingelheim | 2 | $30 |
| GSK | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Itamar Medical Inc | 1 | $18 |
| AstraZeneca | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
| UCB, Inc. | 1 | $11 |
How this compares
$636,143 in reported general payments places this provider in the 95th percentile of 2,979 internal medicine providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 14 | $217 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Baltimore
- Shawn DhillonBaltimore$227K
- Jeremy SugarmanBaltimore$210K
- Charles FlexnerBaltimore$133K
- Kristen MarroneBaltimore$97K
- Ana-Maria OrbaiBaltimore$89K
- Mark YarchoanBaltimore$89K
- David Muniz PedrogoBaltimore$82K
- Julie PaikBaltimore$76K
- Allison AgwuBaltimore$58K
- Jeffrey ThiboutotBaltimore$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.